BioLargo, Inc. (BLGO) stock
BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
$0.07+0.00 (+0.90%)
Close on Oct 19, 2026Market cap $23.27MP/E –Yield –
BioLargo revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
BioLargo's revenue for the twelve months ending Jun 30, 2026 was $4.08M, down 70.9% year over year. For fiscal 2025 it was $7.77M, down 56.3% from the year before. Over ten years it grew 50.8% a year on average. The highest annual figure on record is $17.78M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.77M | -56.3% |
| FY2024 | Dec 31, 2024 | $17.78M | +45.4% |
| FY2023 | Dec 31, 2023 | $12.23M | +107.9% |
| FY2022 | Dec 31, 2022 | $5.88M | +132.5% |
| FY2021 | Dec 31, 2021 | $2.53M | +4.1% |
| FY2020 | Dec 31, 2020 | $2.43M | +30.7% |
| FY2019 | Dec 31, 2019 | $1.86M | +36.4% |
| FY2018 | Dec 31, 2018 | $1.36M | +164.3% |
| FY2017 | Dec 31, 2017 | $516.00K | +83.6% |
| FY2016 | Dec 31, 2016 | $281.11K | +120.3% |
| FY2015 | Dec 31, 2015 | $127.58K | +14.4% |
| FY2014 | Dec 31, 2014 | $111.55K | -33.6% |
| FY2013 | Dec 31, 2013 | $167.95K | +156.2% |
| FY2012 | Dec 31, 2012 | $65.54K | -58.0% |
| FY2011 | Dec 31, 2011 | $156.19K | -0.4% |
| FY2010 | Dec 31, 2010 | $156.76K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.25M | -55.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.12M | -65.9% |
| Q4 FY2025 | Dec 31, 2025 | $617.00K | -83.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.10M | -74.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.78M | -44.6% |
| Q1 FY2025 | Mar 31, 2025 | $3.27M | -31.3% |
| Q4 FY2024 | Dec 31, 2024 | $3.66M | -16.3% |
| Q3 FY2024 | Sep 30, 2024 | $4.35M | +62.8% |
| Q2 FY2024 | Jun 30, 2024 | $5.01M | +246.7% |
| Q1 FY2024 | Mar 31, 2024 | $4.76M | +27.2% |
| Q4 FY2023 | Dec 31, 2023 | $4.37M | +108.3% |
| Q3 FY2023 | Sep 30, 2023 | $2.67M | +78.1% |
| Q2 FY2023 | Jun 30, 2023 | $1.45M | +9.3% |
| Q1 FY2023 | Mar 31, 2023 | $3.74M | +287.8% |
| Q4 FY2022 | Dec 31, 2022 | $2.10M | +166.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.50M | +110.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.32M | +185.1% |
| Q1 FY2022 | Mar 31, 2022 | $965.00K | +69.0% |
| Q4 FY2021 | Dec 31, 2021 | $788.00K | -13.4% |
| Q3 FY2021 | Sep 30, 2021 | $712.00K | +6.9% |
| Q2 FY2021 | Jun 30, 2021 | $464.00K | +11.0% |
| Q1 FY2021 | Mar 31, 2021 | $571.00K | +30.1% |
| Q4 FY2020 | Dec 31, 2020 | $910.00K | +69.5% |
| Q3 FY2020 | Sep 30, 2020 | $666.00K | +24.7% |
| Q2 FY2020 | Jun 30, 2020 | $418.00K | -1.9% |
| Q1 FY2020 | Mar 31, 2020 | $439.00K | +20.6% |
| Q4 FY2019 | Dec 31, 2019 | $537.00K | +8.0% |
| Q3 FY2019 | Sep 30, 2019 | $534.00K | +92.8% |
| Q2 FY2019 | Jun 30, 2019 | $426.00K | +30.3% |
| Q1 FY2019 | Mar 31, 2019 | $364.00K | 0.0% |
| Q4 FY2018 | Dec 31, 2018 | $497.00K | +151.1% |
| Q3 FY2018 | Sep 30, 2018 | $277.00K | +61.0% |
| Q2 FY2018 | Jun 30, 2018 | $327.00K | +227.1% |
| Q1 FY2018 | Mar 31, 2018 | $364.00K | +691.0% |
| Q4 FY2017 | Dec 31, 2017 | $197.96K | +200.6% |
| Q3 FY2017 | Sep 30, 2017 | $172.05K | +6.0% |
| Q2 FY2017 | Jun 30, 2017 | $99.98K | – |
| Q1 FY2017 | Mar 31, 2017 | $46.02K | – |
| Q4 FY2016 | Dec 31, 2016 | $65.86K | – |
| Q3 FY2016 | Sep 30, 2016 | $162.32K | – |
See a number that looks wrong?